IP Library Granted Patent US 12,226,740
Granted Patent B2
US 12,226,740 · App. 17/434,075 · Granted Feb 18, 2025

Stabilized filtration device

Inventors: Simon Isaksson (Stora Höga, SE); Martin Andersson (Mölndal, SE)
Assignee: Retein AB
B01D69/144B01D67/0079B01D67/0088B01D69/106B01D69/107B01D71/027B01D71/74C02F1/44C07K14/39
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,226,740
App. No.
17/434,075
Granted
Feb 18, 2025
Kind
B2
Abstract

A macromolecule membrane structure ( 2 ) comprises a membrane ( 3 ) with water-channeling integral membrane proteins (IMPS) ( 1 ) and is coated, on a first surface, with a silica layer ( 4 ). The silica layer ( 4 ) stabilizes the macromolecule membrane structure ( 2 ) and the water-channeling IMPS ( 1 ) while maintaining the water-channeling function of the water-channeling IMPs ( 1 ). As a consequence of this stabilization, the macromolecule membrane structure ( 2 ) may be used in a filtration device ( 5 ) for various filtration operations, including water purification.

Claims (29)

1. A macromolecule membrane structure comprising:

a membrane that includes water-channeling integral membrane proteins; and

a silica layer that is on a first surface of the membrane,

wherein the membrane is a proteoliposome or a proteopolymersome, and

wherein the first surface of the membrane is the outer surface of the proteoliposome or proteopolymersome.

2. The macromolecule membrane structure according to claim 1 , wherein the membrane is a bilayer membrane comprising amphiphilic molecules.

3. The macromolecule membrane structure according to claim 2 , wherein the membrane is a lipid bilayer membrane that comprises amphiphilic lipids selected from the group consisting of phosphatidylcholine, phosphatidylserine, phosphatidylethanolamine, phosphatidylglycerol, phosphatidylinositol, cardiolipin, cholesterol, sphingomyelin, asolectin, diphytanoylphosphatidylcholine (DPhPC), 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC), 1,2-diheptanoyl-sn-glycero-3-phosphocholine (DHPC), 1,2-dihexanoyl-sn-glycero-3-phosphoethanolamine (DHPE), 1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC), dimyristoyl phosphatidylserine (DMPS), dimyristoyl phosphatidylglycerol, dilauroyl phosphatidycholine (DLPC), 1,2-dimyristoyl-sn-glycero-3-phosphoethanolamine (DMPE), 1,2-dimyristoyl-sn-glycero-3-[phospho-rac-(1-glycerol)] (DMPG), lyso phosphocholine (PC), lyso PE, 1,2-didecanoyl-sn-glycero-3-phosphocholine (DDPC), 1,2-dierucoyl-sn-glycero-3-phosphate (DEPA), 1,2-erucoyl-sn-glycero-3-phosphocholine (DEPC), 1,2-dierucoyi-sn-alycero-3-phosphoethanolamine (DEPE), 1,2-linoleoyl-sn-glycero-3-phosphocholine (DLOPC), 1,2-dilauroyl-sn-glycero-3-phosphate (DLPA), 1,2-dilauroyl-sn-glycerco-3-phosphoethanolamine (DLPE), 1,2-dilauroyl-sn-glycero-3-phosphoserine (DLPS), 1,2-dimyristoyl-sn-glycero-3-phosphate (DMPA), 1,2-dimyristoyl-sn-glycero-3-phosphoserine (DMPS), 1,2-dioleoyl-sn-glycero-3-phosphate (DOPA), 1,2-oleoyl-sn-glycero-3-phosphocholine (DOPC), 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE), 1,2-dioleoyl-sn-glycero-3-phosphoserine (DOPS), 1,2-dipalmitoyl-sn-glycero-3-phosphate (DPPA), 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine (DPPE), 1,2-dipalmitoyl-sn-glycerco-3-phosphoserine (DPPS), 1,2-distearoyl-sn-glycero-3-phosphate (DSPA), 1,2-distearoyl-sn-glycero-3-phosphocholine (DSPC), 1,2-diostearpyl-sn-glycero-3-phosphoethanolamine (DSPE), 1-myristoyl-2-stearoyl-sn-glycero-3-phosphocholine (MSPC), 1-palmitoyl-2-myristoyl-sn-glycero-3-phosphocholine (PMPC), 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC), 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine (POPE), 1-palmitoyl-2-stearoyl-sn-glycero-3-phosphocholine (PSPC), 1-stearoyl-2-myristoyl-sn-glycero-3-phosphocholine (SMPC), 1-stearoyl-2-oleoyl-sn-glycero-3-phosphocholine (SOPC), 1-stearoyl-2-palmitoyl-sn-glycero-3-phosphocholine (SPPC), a lipid from a cell membrane, a lipid from an organelle, a cross-linkable lipid, and a mixture thereof.

4. The macromolecule membrane structure according to claim 2 , wherein the amphiphilic molecules are selected from amphiphilic AB, ABA and ABC copolymers, and mixtures thereof.

5. The macromolecule membrane structure according to claim 1 , wherein the water-channeling integral membrane proteins are aquaporins.

6. The macromolecule membrane structure according to claim 1 , wherein the silica layer has an average thickness in a range of from 0.1 nm to 1000 nm.

7. The macromolecule membrane structure according to claim 1 , wherein the water-channeling integral membrane proteins are capable of channeling water through the membrane in the presence of the silica layer.

8. The macromolecule membrane structure according to claim 1 , wherein the silica layer is a functionalized silica layer.

9. A filtration device comprising:

a porous support comprising a plurality of pores; and

the macromolecule membrane structure according to claim 1 .

10. The filtration device according to claim 9 , wherein the macromolecule membrane structure is provided on a surface of the porous support and/or in a pore of the porous support.

11. The filtration device according to claim 9 , wherein the porous support comprises a material selected from the group consisting of a polymer, a metal, an oxide of the metal, a silicon dioxide, a glass fiber, and a mixture thereof.

12. The filtration device according to claim 9 , wherein

functional groups of the silica layer link the macromolecule membrane structure to the porous support.

13. A method of preparing a water filtrate, the method comprising filtering an aqueous solution through the macromolecule membrane structure according to claim 1 to obtain the water filtrate.

14. A method for concentrating a compound dissolved or dispersed in an aqueous solution, the method comprising filtering the aqueous solution through the macromolecule membrane structure according to claim 1 to obtain a water filtrate lacking the compound and a retentate comprising the compound at a higher concentration than the aqueous solution.

15. The macromolecule membrane structure according to claim 5 , wherein the aquaporins are selected from the group consisting of a human aquaporin (hAQP), a bovine aquaporin, a fish aquaporin, a yeast aquaporin, a plant aquaporin, a bacterial aquaporin, and a mixture thereof.

16. The macromolecule membrane structure according to claim 1 , wherein the silica layer has an average thickness in a range of from 1 nm to 100 nm.

17. The macromolecule membrane structure according to claim 8 , wherein the functionalized silica layer comprises a silane, an alkoxysilane, hexamethyldisilazane (HMDZ), or a combination thereof.

18. A process for preparation of the macromolecule membrane structure of claim 1 , the process comprising contacting the membrane comprising the water-channeling integral membrane proteins with a silica precursor to form the silica layer on the first surface of the membrane.

19. A process for preparation of a filtration device, the process comprising:

depositing the membrane comprising the water-channeling integral membrane proteins onto and/or into a porous support; and

contacting the membrane comprising the water-channeling integral membrane proteins that is deposited onto and/or into the porous support with a silica precursor to form the silica layer on the first surface of the membrane.

20. The process according to claim 18 , wherein the silica precursor is selected from the group consisting of a silicon alkoxide, a silane, a silicate, a silanol, a silazane, and any combination thereof.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 10, 2024
From: ISAKSSON, SIMON; ANDERSSON, MARTIN
To: AQUAMMODATE AB
Reel/Frame 066074/0745 →
CHANGE OF NAME Recorded Jan 10, 2024
From: AQUAMMODATE AB
To: RETEIN AB
Reel/Frame 066254/0344 →
Priority Claims (1)
SE 1950252-5 · Feb 27, 2019 · national
Continuity (1)
Related Publication 20220152559A1 · May 19, 2022
References Cited (13)
US 9943812B2 · Jeon et al. · 2018 [cited by applicant]
US 20110259815A1 · Montemagno · 2011 [cited by applicant]
US 20110284456A1 · Brozell · 2011 [cited by applicant]
US 20160367949A1 · Jeon et al. · 2016 [cited by applicant]
WO 2010040353A2 · 2010 [cited by applicant]
WO 2010091078A2 · 2010 [cited by applicant]
WO 2015144724A1 · 2015 [cited by applicant]
Besanger et al. “Ion Sensing and Inhibition Studies Using the Transmembrane Ion Channel Peptide Gramicidin A Entrapped in Sol-Gel-Derived Silica” Analytical Chemistry, 75(5):1094-1101 (2003). [cited by applicant]
International Search Report and the Written Opinion of the International Searching Authority corresponding to International Patent Application No. PCT/SE2020/050213 (12 pages) (mailed May 26, 2020). [cited by applicant]
Luo et al. “Photo-induced proton gradients and ATP biosynthesis produced by vesicles encapsulated in a silica matrix” Nature Materials, 4(3):220-224 (2005). [cited by applicant]
Ji et al. “Recent developments in nanofiltration membranes based on nanomaterials” Chinese Journal of Chemical Engineering, 25:1639-1652 (2017). [cited by applicant]
Keiderling, U. “The new ‘BerSANS-PC’ software for reduction and treatment of small angle neutron scattering data” Applied Physics A: Materials Science and Processing, 74:S1455-S1457 (2002). [cited by applicant]
Nyblom et al. “Exceptional overproduction of a functional human membrane protein” Protein Expression and Purification, 56:110-120 (2007). [cited by applicant]